Shareholder Alert: Ademi LLP investigates whether Paratek Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Gurnet Point Capital and Novo Holdings

MILWAUKEE, June 8, 2023 /PRNewswire/ -- Ademi LLP is investigating Paratek (Nasdaq: PRTK) for possible breaches of fiduciary duty and other violations of law in its transaction with Gurnet Point Capital and Novo Holdings. 

Read more at prnewswire.com